or
forgot password

    • cancer clinical trials in burbank, CA

    • Chemotherapy or Observation in Treating Patients With Early Stage Non-Small Cell Lung Cancer
    Roy and Patricia Disney Family Cancer Center at Providence Saint Joseph Medical Center
    Burbank, California 91505
    Lung Cancer
    S0904: Docetaxel With or Without Vandetanib in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
    Roy and Patricia Disney Family Cancer Center at Providence Saint Joseph Medical Center
    Burbank, California 91505
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Bevacizumab With or Without Everolimus in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
    Providence Saint Joseph Medical Center
    Burbank, California 91505-4866
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Collecting Tumor Samples From Patients With Gynecological Tumors
    Roy and Patricia Disney Family Cancer Center at Providence Saint Joseph Medical Center
    Burbank, California 91505
    Cancer
    Tumor Marker YKL-40 in Patients With Newly Diagnosed Stage III or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer Undergoing Chemotherapy
    Roy and Patricia Disney Family Cancer Center at Providence Saint Joseph Medical Center
    Burbank, California 91505
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    S9925: Collecting and Storing Samples From Patients With Lung Cancer
    Providence Saint Joseph Medical Center - Burbank
    Burbank, California 91505
    Lung Cancer
    Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate Cancer
    Roy and Patricia Disney Family Cancer Center at Providence Saint Joseph Medical Center
    Burbank, California 91505
    Prostate Cancer
    PEAK PlasmaBlade™ 4.0 Versus Traditional Electrosurgery in Mastectomy
    Provident St. Joseph's Medical Center
    Burbank, California 94505
    Mastectomy
    Bevacizumab and Intravenous or Intraperitoneal Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
    Providence Saint Joseph Medical Center
    Burbank, California 91505-4866
    Brenner Tumor, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Stage IIA Fallopian Tube Cancer, Stage IIA Ovarian Epithelial Cancer, Stage IIA Primary Peritoneal Cavity Cancer, Stage IIB Fallopian Tube Cancer, Stage IIB Ovarian Epithelial Cancer, Stage IIB Primary Peritoneal Cavity Cancer, Stage IIC Fallopian Tube Cancer, Stage IIC Ovarian Epithelial Cancer, Stage IIC Primary Peritoneal Cavity Cancer, Stage IIIA Fallopian Tube Cancer, Stage IIIA Ovarian Epithelial Cancer, Stage IIIA Primary Peritoneal Cavity Cancer, Stage IIIB Fallopian Tube Cancer, Stage IIIB Ovarian Epithelial Cancer, Stage IIIB Primary Peritoneal Cavity Cancer, Stage IIIC Fallopian Tube Cancer, Stage IIIC Ovarian Epithelial Cancer, Stage IIIC Primary Peritoneal Cavity Cancer, Stage IV Fallopian Tube Cancer, Stage IV Ovarian Epithelial Cancer, Stage IV Primary Peritoneal Cavity Cancer
    Paclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed Persistent or Recurrent Uterine or Ovarian Cancer
    Roy and Patricia Disney Family Cancer Center at Providence Saint Joseph Medical Center
    Burbank, California 91505
    Ovarian Cancer, Sarcoma
    Paclitaxel, Carboplatin, and Bevacizumab or Paclitaxel, Carboplatin, and Temsirolimus or Ixabepilone, Carboplatin, and Bevacizumab in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer
    Providence Saint Joseph Medical Center
    Burbank, California 91505-4866
    Endometrial Adenocarcinoma, Endometrial Adenosquamous Cell Carcinoma, Endometrial Clear Cell Carcinoma, Recurrent Endometrial Carcinoma, Stage III Endometrial Carcinoma, Stage IV Endometrial Carcinoma
    Gemcitabine Hydrochloride and Docetaxel With or Without Bevacizumab in Treating Patients With Advanced or Recurrent Uterine Leiomyosarcoma
    Providence Saint Joseph Medical Center
    Burbank, California 91505-4866
    Recurrent Uterine Sarcoma, Stage IIIA Uterine Sarcoma, Stage IIIB Uterine Sarcoma, Stage IIIC Uterine Sarcoma, Stage IVA Uterine Sarcoma, Stage IVB Uterine Sarcoma, Uterine Leiomyosarcoma
    BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
    Providence Health System: Roy and Patricia Disney Family Cancer Center
    Burbank, California 91505
    Renal Cell Carcinoma
    AMG 102 in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
    Roy and Patricia Disney Family Cancer Center at Providence Saint Joseph Medical Center
    Burbank, California 91505
    Fallopian Tube Cancer, Ovarian Cancer, Malignant Tumor of Peritoneum
    Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian Stromal Tumors
    Roy and Patricia Disney Family Cancer Center at Providence Saint Joseph Medical Center
    Burbank, California 91505
    Ovarian Cancer
    Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving Chemotherapy
    Roy and Patricia Disney Family Cancer Center at Providence Saint Joseph Medical Center
    Burbank, California 91505
    Cognitive/Functional Effects, Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Carboplatin and Paclitaxel or Oxaliplatin and Capecitabine, With or Without Bevacizumab, as First-Line Therapy in Treating Patients With Newly Diagnosed Stage II, Stage III, Stage IV, or Recurrent Stage I Epithelial Ovarian Cancer or Fallopian Tube Cancer
    Providence Saint Joseph Medical Center
    Burbank, California 91505-4866
    Ovarian Mucinous Cystadenocarcinoma, Ovarian Mucinous Cystadenoma With Proliferating Activity, Recurrent Fallopian Tube Cancer, Recurrent Ovarian Epithelial Cancer, Stage IA Fallopian Tube Cancer, Stage IA Ovarian Epithelial Cancer, Stage IB Fallopian Tube Cancer, Stage IB Ovarian Epithelial Cancer, Stage IC Fallopian Tube Cancer, Stage IC Ovarian Epithelial Cancer, Stage IIA Fallopian Tube Cancer, Stage IIA Ovarian Epithelial Cancer, Stage IIB Fallopian Tube Cancer, Stage IIB Ovarian Epithelial Cancer, Stage IIC Fallopian Tube Cancer, Stage IIC Ovarian Epithelial Cancer, Stage IIIA Fallopian Tube Cancer, Stage IIIA Ovarian Epithelial Cancer, Stage IIIB Fallopian Tube Cancer, Stage IIIB Ovarian Epithelial Cancer, Stage IIIC Fallopian Tube Cancer, Stage IIIC Ovarian Epithelial Cancer, Stage IV Fallopian Tube Cancer, Stage IV Ovarian Epithelial Cancer
    Radiation Therapy in Treating Women With Locally Recurrent Breast Cancer Previously Treated With Repeat Breast-Preserving Surgery
    Roy and Patricia Disney Family Cancer Center at Providence Saint Joseph Medical Center
    Burbank, California 91505
    Breast Cancer
    Patient, Physician, and Nurse Factors Associated With Entry Onto Clinical Trials and Finishing Treatment in Patients With Primary or Recurrent Uterine, Endometrial, or Cervical Cancer
    Roy and Patricia Disney Family Cancer Center at Providence Saint Joseph Medical Center
    Burbank, California 91505
    Cervical Cancer, Endometrial Cancer, Sarcoma
    Radiation Therapy With or Without Chemotherapy in Patients With Stage I or Stage II Cervical Cancer Who Previously Underwent Surgery
    Roy and Patricia Disney Family Cancer Center at Providence Saint Joseph Medical Center
    Burbank, California 91505
    Cervical Cancer
    Cediranib Maleate in Treating Patients With Recurrent or Persistent Endometrial Cancer
    Providence Saint Joseph Medical Center
    Burbank, California 91505-4866
    Endometrial Adenocarcinoma, Endometrial Adenosquamous Cell Carcinoma, Endometrial Clear Cell Carcinoma, Endometrial Papillary Serous Carcinoma, Recurrent Endometrial Carcinoma
    Efficacy Study of REOLYSIN® in Combination With Paclitaxel and Carboplatin in Platinum-Refractory Head and Neck Cancers
    Providence Health and Services
    Burbank, California 91505
    Carcinoma, Squamous Cell of the Head and Neck
    Paclitaxel and Carboplatin With or Without Bevacizumab in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer
    Providence Saint Joseph Medical Center
    Burbank, California 91505-4866
    Brenner Tumor, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Stage IIA Fallopian Tube Cancer, Stage IIA Ovarian Epithelial Cancer, Stage IIA Primary Peritoneal Cavity Cancer, Stage IIB Fallopian Tube Cancer, Stage IIB Ovarian Epithelial Cancer, Stage IIB Primary Peritoneal Cavity Cancer, Stage IIC Fallopian Tube Cancer, Stage IIC Ovarian Epithelial Cancer, Stage IIC Primary Peritoneal Cavity Cancer, Stage IIIA Fallopian Tube Cancer, Stage IIIA Ovarian Epithelial Cancer, Stage IIIA Primary Peritoneal Cavity Cancer, Stage IIIB Fallopian Tube Cancer, Stage IIIB Ovarian Epithelial Cancer, Stage IIIB Primary Peritoneal Cavity Cancer, Stage IIIC Fallopian Tube Cancer, Stage IIIC Ovarian Epithelial Cancer, Stage IIIC Primary Peritoneal Cavity Cancer, Stage IV Fallopian Tube Cancer, Stage IV Ovarian Epithelial Cancer, Stage IV Primary Peritoneal Cavity Cancer
    Study for Women With Platinum Resistant Ovarian Cancer Evaluating EC145 in Combination With Doxil® (PROCEED)
    Providence Saint Joseph Medical Center
    Burbank, California 91505-4866
    Ovarian Cancer
    Temsirolimus, Carboplatin, and Paclitaxel as First-Line Therapy in Treating Patients With Newly Diagnosed Stage III or Stage IV Clear Cell Ovarian Cancer
    Providence Saint Joseph Medical Center
    Burbank, California 91505-4866
    Ovarian Clear Cell Cystadenocarcinoma, Stage III Ovarian Epithelial Cancer, Stage IV Ovarian Epithelial Cancer
    Study of Lenalidomide to Evaluate Safety and Effectiveness in Patients With Diffuse Large B-Cell Lymphoma (DLBCL)
    Roy and Patricia Disney Family Cancer Center
    Burbank, California 91505
    Diffuse Large B-cell Lymphoma
    Paclitaxel With or Without Viral Therapy in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer
    Providence Saint Joseph Medical Center
    Burbank, California 91505-4866
    Recurrent Fallopian Tube Cancer, Recurrent Ovarian Epithelial Cancer, Recurrent Primary Peritoneal Cavity Cancer
    CMR Rate of Newly Diagnosed CML-CP Patients Treated With Nilotinib
    Providence St. Joseph Medical Center Roy&Patricia Disney Fam Cancer
    Burbank, California 91505-6866
    Chronic Myelogenous Leukemia in Chronic Phase
    Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer
    Providence Saint Joseph Medical Center

    Trial Locations
    Providence Saint Joseph Medical Center
    Roy and Patricia Disney Family Cancer Center
    Estrogen Receptor-negative Breast Cancer, Estrogen Receptor-positive Breast Cancer, HER2-positive Breast Cancer, Progesterone Receptor-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Recurrent Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIC Breast Cancer
    Study of Ombrabulin in Patients With Platinum-Sensitive Recurrent Ovarian Cancer Treated With Carboplatin/Paclitaxel
    Investigational Site Number 840007
    Burbank, California 91505
    Ovarian Cancer Recurrent
    Paclitaxel With or Without Pazopanib Hydrochloride in Treating Patients With Persistent or Recurrent Ovarian Epithelial, Fallopian Tube, or Peritoneal Cavity Cancer
    Providence Saint Joseph Medical Center
    Burbank, California 91505-4866
    Recurrent Fallopian Tube Cancer, Recurrent Ovarian Epithelial Cancer, Recurrent Primary Peritoneal Cavity Cancer
    Combined Rituximab and Lenalidomide Treatment for Untreated Patients With Follicular Lymphoma
    Providence Saint Joseph Medical Center
    Burbank, California 91505-4866
    Follicular Lymphoma
    Efficacy and Safety of GS-6624 With FOLFIRI as Second Line Treatment in Colorectal Adenocarcinoma
    Providence Saint Joseph Medical Center-Disney Family Cancer Center
    Burbank, California
    Colorectal Cancer
    Alisertib (MLN8237) or Investigator's Choice in Patients With Relapsed/Refractory Peripheral T-Cell Lymphoma
    Providence Saint Joseph Medical Center
    Burbank, California 91505-4866
    Relapsed Peripheral T-Cell Lymphoma, Refractory Peripheral T-Cell Lymphoma
    Gemcitabine+Nab-paclitaxel and FOLFIRINOX and Molecular Profiling for Patients With Advanced Pancreatic Cancer
    Disney Family Cancer Center
    Burbank, California 91505
    Stage IV Pancreatic Cancer
    The BEACON Study (Breast Cancer Outcomes With NKTR-102)
    Providence Health System - Southern California d/b/a Roy and Patricia Disney Family Cancer Center
    Burbank, California 91505
    Locally Recurrent Breast Cancer, Metastatic Breast Cancer
    Morphotek Investigation in Colorectal Cancer: Research of MORAb-004 (MICRO)
    Providence St. Joseph Medical Center-Disney Family Cancer Center
    Burbank, California 91505
    Metastatic Colorectal Cancer, Colorectal Cancer
    Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast Cancer
    Providence Saint Joseph Medical Center
    Burbank, California 91505-4866
    Breast Cancer
    Phase 3 Study With Carfilzomib and Dexamethasone Versus Velcade and Dexamethasone for Relapsed Multiple Myeloma Patients
    Providence Saint Joseph Medical Center
    Burbank, California 91505-4866
    Multiple Myeloma
    Phase 2 Study of EC145 Alone Versus EC145+Docetaxel Versus Docetaxel Alone in Participants With FR(++) 2nd Line Non Small Cell Lung Cancer
    Providence Saint Joseph Medical Center
    Burbank, California 91505-4866
    Non Small Cell Lung Cancer
    Study of the Effect of GTx-758 on Serum PSA and Testosterone in Men With Prostate Cancer
    Urology Associates Medical Group
    Burbank, California 91505
    Prostate Cancer
    Afatinib Expanded Access Program
    1200.45.114 Boehringer Ingelheim Investigational Site
    Burbank, California
    Carcinoma, Non-Small-Cell Lung
    Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)
    US Oncology - Providence Health System, Site #167
    Burbank, California 91505
    Chronic Myeloid Leukemia
    VTX-2337 and Pegylated Liposomal Doxorubicin (PLD) in Patients With Recurrent or Persistent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer
    Providence Saint Joseph Medical Center
    Burbank, California 91505-4866
    Epithelial Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer
    Diagnostic Study for Lung Cancer Detection Test
    Providence-St. Joseph Health Systems, Disney Family Cancer Center
    Burbank, California 91505
    Lung Cancer
    A Study of Brentuximab Vedotin in Adults Age 60 and Above With Newly Diagnosed Hodgkin Lymphoma (HL)
    Providence St Joseph Medical Center
    Burbank, California 91505
    Hodgkin Disease
    A Study Evaluating the Efficacy and Safety of Idelalisib (GS-1101) in Combination With Rituximab for Previously Treated Indolent Non-Hodgkin Lymphomas
    Providence Saint Joseph Medical Center-Disney Family Cancer Center
    Burbank, California
    Indolent Non-Hodgkin's Lymphomas
    A Study Evaluating the Efficacy and Safety of Idelalisib(GS-1101) in Combination With Bendamustine and Rituximab for Previously Treated Indolent Non-Hodgkin Lymphomas
    Providence Saint Joseph Medical Center-Disney Family Cancer Center
    Burbank, California
    Indolent Non-Hodgkin's Lymphomas
    ECHELON-2: A Comparison of Brentuximab Vedotin and CHP With Standard-of-care CHOP in the Treatment of Patients With CD30-positive Mature T-cell Lymphomas
    Providence St Joseph Medical Center
    Burbank, California 91505
    Lymphoma, Large-Cell, Anaplastic, Lymphoma, Non-Hodgkin, Lymphoma, T-Cell
    A Phase 2 of GS-9973 in Subjects With Relapsed or Refractory Hematologic Malignancies
    Providence Saint Joseph Medical Center
    Burbank, California 91505-4866
    Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma, Indolent Non-Hodgkin's Lymphoma
    Radiation Therapy Plus Chemotherapy in Treating Patients With Supratentorial Glioblastoma Multiforme
    Providence Saint Joseph Medical Center - Burbank
    Burbank, California 91505
    Brain and Central Nervous System Tumors
    Talc in Treating Patients With Malignant Pleural Effusion
    Providence Saint Joseph Medical Center - Burbank
    Burbank, California 91505
    Metastatic Cancer
    Laparoscopic Surgery or Standard Surgery in Treating Patients With Endometrial Cancer or Cancer of the Uterus
    Providence Saint Joseph Medical Center - Burbank
    Burbank, California 91505
    Endometrial Cancer, Sarcoma
    Chemotherapy Plus Radiation Therapy Followed by Surgery in Treating Patients With Soft Tissue Sarcoma
    Providence Saint Joseph Medical Center - Burbank
    Burbank, California 91505
    Sarcoma
    Radiation Therapy in Treating Women With Stage I or Stage II Breast Cancer
    Providence Saint Joseph Medical Center - Burbank
    Burbank, California 91505
    Breast Cancer
    Brachytherapy in Treating Patients With Prostate Cancer
    Providence Saint Joseph Medical Center - Burbank
    Burbank, California 91505
    Prostate Cancer
    Radiation Therapy Plus Paclitaxel in Treating Patients With Nonmetastatic, Unresectable Pancreatic Cancer
    Providence Saint Joseph Medical Center - Burbank
    Burbank, California 91505
    Pancreatic Cancer
    Chemotherapy Plus Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer
    Providence Saint Joseph Medical Center - Burbank
    Burbank, California 91505
    Anal Cancer